The differential response to immune checkpoint inhibitors (ICIs) according to mismatch repair alterations in gastrointestinal (GI) non-colorectal cancers (non-CRCs) and the impact of dual vs.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results